Cleared Traditional

K921595 - Y-TYPE BLOOD ADMINISTRATION SET MODEL #...

K921595 is an FDA 510(k) clearance for Y-TYPE BLOOD ADMINISTRATION SET MODEL #..., manufactured by Haemotronic, Inc.. The device is a Class 2 General Hospital device with product code BRZ cleared through the Traditional 510(k) pathway after a 265-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1992
Decision
265d
Days
Class 2
Risk

K921595 is an FDA 510(k) clearance for the Y-TYPE BLOOD ADMINISTRATION SET MODEL #HT-TR2. Classified as Set, Blood Transfusion (product code BRZ), Class II - Special Controls.

Submitted by Haemotronic, Inc. (Fairfield, US). The FDA issued a Cleared decision on December 24, 1992 after a review of 265 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Haemotronic, Inc. devices

FDA 510(k) Submission Details - K921595

510(k) Number K921595 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 1992
Decision Date December 24, 1992
Days to Decision 265 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 129d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BRZ Device Classification - Class 2, Special Controls

Product Code BRZ Set, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - BRZ Set, Blood Transfusion

Devices cleared under the same product code (BRZ) and FDA review panel - the closest regulatory comparables to K921595.
Blood Administration Sets
K220558 · Baxter Healthcare Corporation · Nov 2022
Blood Administration Set
K210335 · Baxter Healthcare Corporation · Jun 2021
MODIFIED BLOOD RECIPIENT SET
K993120 · Baxter Healthcare Corp · Nov 1999
IV ADMINISTRATION SET
K871908 · Travenol Laboratories, S.A. · Jul 1987
CHURCHILL BLOOD ADMINISTRATION SET
K864441 · Churchill Corp. · Jan 1987
VYGON EXCHANGE TRANSFUSION TRAY 275.00
K851477 · Vygon Corp. · May 1985